Recent Updates and Announcements


< View All Updates And Announcements

Class l Recall of Eliquis (apixaban) 5mg tablets
Posted By Admin on August 02, 2017
Tags: Class l Recall of Eliquis
Text Size

Bristol-Myers Squibb voluntarily recalled one lot of Eliquis (apixaban) 5mg tablets on June 10, 2017. This recall was classified as a Class I Recall on July 19, 2017 by the Food and Drug Administration (FDA).

The lot was recalled due to a single customer complaint that a bottle labeled as Eliquis 5 mg was found to contain Eliquis 2.5 mg tablets. No other lots are impacted by this recall. The lot was distributed nationwide in the U.S. to wholesalers and retail pharmacies in February 2017.

Please visit for more information.